Federal Contractor Profile
Fundacion Inciensa
$115M obligated·14 awards·1 agencies·3 NAICS
Federal Contracts
Showing award actions 1–33 of 33 funded award actions, most recent first.
- Contracts with positive obligations
- 14
- Funded award actions shown
- 33
- Obligations shown
- $115M
- Awarding agencies
- 1
This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.
Award data as of August 27, 2026. Source: USAspending federal award records.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Aug 27, 2026 | Department of Health and Human ServicesNIH NCI | 75N91025F00001 | 541720 | EXTENSION OF ESCUDDO FOLLOW-UP FROM FIVE YEARS TO 7.5 YEARS (REFERRED TO AS ESCUDDO-7) WILL EVALUATE THE DURABILITY OF THE NON-INFERIORITY OF PROTECTION AFFORDED BY ONE VERSUS TWO DOSES OF THE HPV VACCINES. | $214K |
| Jan 22, 2026 | Department of Health and Human ServicesNIH NCI | 75N91023F00001 | 541720 | PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS | $1.5M |
| May 21, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00001 | 541720 | EXTENSION OF ESCUDDO FOLLOW-UP FROM FIVE YEARS TO 7.5 YEARS (REFERRED TO AS ESCUDDO-7) WILL EVALUATE THE DURABILITY OF THE NON-INFERIORITY OF PROTECTION AFFORDED BY ONE VERSUS TWO DOSES OF THE HPV VACCINES. | $6.0M |
| May 8, 2025 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $227K |
| Mar 13, 2025 | Department of Health and Human ServicesNIH NCI | 75N91025F00001 | 541720 | EXTENSION OF ESCUDDO FOLLOW-UP FROM FIVE YEARS TO 7.5 YEARS (REFERRED TO AS ESCUDDO-7) WILL EVALUATE THE DURABILITY OF THE NON-INFERIORITY OF PROTECTION AFFORDED BY ONE VERSUS TWO DOSES OF THE HPV VACCINES. | $3.6M |
| Dec 20, 2024 | Department of Health and Human ServicesNIH NCI | 75N91023F00001 | 541720 | PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS | $2.4M |
| Sep 11, 2024 | Department of Health and Human ServicesNIH NCI | 75N91022F00002 | 541720 | LAB TESTING OF BIOSPECIMENS COLLECTED FROM PARTICIPANTS OF THE NCI'S HPV VACCINE STUDIES | $650K |
| Sep 5, 2024 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $3.1M |
| Aug 29, 2024 | Department of Health and Human ServicesNIH NCI | 75N91024F00001 | 541720 | KICK-OFF OF EPIDEMIOLOGY AND PREVENTION OF INFECTIONS AND RELATED DISEASES IDIQ | $3K |
| Jan 22, 2024 | Department of Health and Human ServicesNIH NCI | 75N91023F00001 | 541720 | PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS | $1.7M |
| Sep 11, 2023 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $9.0M |
| Aug 28, 2023 | Department of Health and Human ServicesNIH NCI | 75N91022F00002 | 541720 | LAB TESTING OF BIOSPECIMENS COLLECTED FROM PARTICIPANTS OF THE NCI'S HPV VACCINE STUDIES | $538K |
| Jan 10, 2023 | Department of Health and Human ServicesNIH NCI | 75N91023F00001 | 541720 | PRISMA AND EXTEND 2.0 FOLLOW-UP OF STUDY PARTICIPANTS | $1.4M |
| Sep 19, 2022 | Department of Health and Human ServicesNIH NCI | 75N91022F00002 | 541720 | LAB TESTING OF BIOSPECIMENS COLLECTED FROM PARTICIPANTS OF THE NCI'S HPV VACCINE STUDIES | $197K |
| Sep 2, 2022 | Department of Health and Human ServicesNIH NCI | 75N91019F00130 | 541720 | FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL | $239K |
| Aug 31, 2022 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $9.4M |
| Nov 15, 2021 | Department of Health and Human ServicesNIH NCI | 75N91022F00001 | 541720 | THIS TASK ORDER DESCRIBES ACTIVITIES RELATED TO NCIS HUMAN PAPILLOMAVIRUS HPV VACCINE EVALUATION EFFORTS REQUIRED FOR THE NEXT PHASE OF THE RESEARCH | $4.0M |
| Sep 14, 2021 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $9.3M |
| Sep 14, 2021 | Department of Health and Human ServicesNIH NCI | 75N91019F00130 | 541720 | FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL | $296K |
| Aug 31, 2021 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $7K |
| Sep 21, 2020 | Department of Health and Human ServicesNIH NCI | 75N91020F00001 | 541720 | TO STUDY COVID TRANSMISSION IN COSTA RICA | $366K |
| Sep 15, 2020 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $8.6M |
| Sep 15, 2020 | Department of Health and Human ServicesNIH NCI | 75N91019F00130 | 541720 | FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL | $261K |
| Jul 31, 2020 | Department of Health and Human ServicesNIH NCI | 75N91020F00001 | 541720 | TO STUDY COVID TRANSMISSION IN COSTA RICA | $334K |
| Sep 16, 2019 | Department of Health and Human ServicesNIH NCI | 75N91019F00130 | 541720 | FOLLOW-UP OF PARTICIPANTS ENROLLED IN THE PRIMAVERA-ESCUDDO TRIAL | $73K |
| Sep 9, 2019 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $8.6M |
| Feb 28, 2019 | Department of Health and Human ServicesNIH NCI | 75N91019F00129 | 541720 | PRIMAVERA-ESCUDDO TRIAL; PERFORMANCE PERIOD: MARCH 1, 2019 THROUGH SEPTEMBER 15, 2020; CAN: 9-8030021 | $2.0M |
| Sep 5, 2018 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $5.4M |
| Apr 6, 2018 | Department of Health and Human ServicesNIH NCI | 75N91018F00002 | 541720 | IGF::OT::IGF FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | $1.5M |
| Aug 1, 2017 | Department of Health and Human ServicesNIH NCI | HHSN26100001 | 541720 | IGF::OT::IGF TASK ORDER 1: ONE-DOSE TRIAL SETUP, ENROLLMENT AND IMMUNIZATION | $23M |
| Oct 28, 2016 | Department of Health and Human ServicesNIH NCI | HHSN261201200006C | 541712 | IGF::OT::IGF HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA | $2.6M |
| Jul 29, 2016 | Department of Health and Human ServicesNIH NCI | HHSN261201600010C | 541990 | IGF::OT::IGF EXIT OF CVT PARTICIPANTS AND PLANNING YEAR FOR ONE DOSE TRIAL | $6.9M |
| Feb 24, 2016 | Department of Health and Human ServicesNIH, NCI, OD OM OA OFC ACQUISITIONS | HHSN261201200006C | 541712 | IGF::OT::IGF HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VACCINE TRIAL IN COSTA RICA | $1.3M |
Get Alerted Before Fundacion Inciensa's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start for free